Psyence Group's NASDAQ Listed Associate, Psyence
NEW YORK, March 12, 2024 (GLOBE NEWSWIRE) -- Psyence Group Inc (
Source: globenewswire.com
📰 Psyence Function News
Psyence Function News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Psyence Function. Real-time updates on events, politics, business and more.
Psyence Group's NASDAQ Listed Associate, Psyence Biomedical, Receives Human Research Ethics Committee (HREC) Approval to Initiate Phase IIb Study
NEW YORK, March 12, 2024 -- Psyence Group Inc , a clinical-stage life science biotechnology company pioneering the use of nature-derived psilocybin in mental health and wellbeing, is pleased to...
Source: marketscreener.com
Psyence Biomedical Ltd. Approved to List on Nasdaq following Completion of Business Combination ...
TORONTO, Jan. 25, 2024 (GLOBE NEWSWIRE) -- Psyence Biomedical Ltd. (“Psyence Biomed”) is excited to announce the completion of its merger (the “Business Combination”) with Newcourt Acquisition Corp ("Newcourt"), a
United Kingdom United States Commonwealth Of Australia Neil Maresky Psyence Biomed Newcourt Acquisition Corp
Source: eagletribune.com
Psyence Biomedical Ltd. Approved to List on Nasdaq following Completion of Business Combination Agreement with Newcourt Acquisition Corp
TORONTO, Jan. 25, 2024 (GLOBE NEWSWIRE) — Psyence Group Inc (“Psyence Group”), a clinical-stage life science biotechnology company pioneering the use of…
Source: financialpost.com
Newcourt Acquisition Corp Announces Continuation of Business Combination Close Process
NEW YORK, NY, Jan. 22, 2024 -- Newcourt Acquisition Corp announced today that the conditions to closing the business combination pursuant to the Amended and Restated Business Combination...
United States United Kingdom Marc Balkin Newcourt Acquisition Corp Psyence Biomed Corp Canadian Securities Exchange
Source: marketscreener.com
Psyence Group Inc Subsidiary Psyence Biomedical Ltd. announces signing of definitive agreement for a convertible note in connection with planned business combination
TORONTO, Jan. 16, 2024 -- Psyence Group Inc , a clinical-stage life science biotechnology company pioneering the use of nature-derived psilocybin in mental health and wellbeing, today announced...
United States United Kingdom Neil Maresky Psyence Biomed Newcourt Acquisition Company Psyence Biomedical Ltd Pubco
Source: marketscreener.com
Psyence Group Inc Subsidiary Psyence Biomedical Ltd.
TORONTO, Jan. 16, 2024 (GLOBE NEWSWIRE) -- Psyence Group Inc (
United Kingdom United States Psyence Biomed Neil Maresky Psyence Group Inc Canadian Securities Exchange
Source: globenewswire.com
Psyence Group Announces Closing of Private Placement &
TORONTO, Aug. 21, 2023 (GLOBE NEWSWIRE) -- Psyence Group Inc. (CSE:PSYG | OTCQB:PSYGF) (“Psyence” or the “Company”), a life science biotechnology company...
United States United Kingdom Katherine Murphy Canadian Securities Exchange Australian Taxation Office Australian Federal Government Research Development
Source: globenewswire.com
Psyence Group Announces Closing of Private Placement & Conclusion of Loan Agreement
TORONTO, Aug. 21, 2023 -- Psyence Group Inc. , a life science biotechnology company pioneering the use of natural psychedelics in mental health and well-being, announces that it has issued...
United States United Kingdom Katherine Murphy Rh Capital Finance Co Psyence Group Inc Australian Federal Government Research Development
Source: marketscreener.com
Psyence Group Announces SEC Registration Filing with NASDAQ SPAC, Newcourt, and Signing of Amended and Restated Business Combination Agreement
VANCOUVER, British Columbia, Aug. 02, 2023 -- Psyence Group Inc. , a clinical-stage life science biotechnology company pioneering the use of natural psilocybin in mental health and well-being , and...
Source: marketscreener.com